Noted for its ‘significant experience’ and ‘pragmatic advice’, Bristows LLP is adept at handling day-to-day operational contracts, as well as contracts related to large commercial transactions. The group is prolific in the pharmaceutical and IP industries, calling upon the biochemistry knowledge of practice head Richard Dickinson, who brings significant expertise in commercial transactions to clients. Major clients include international conglomerates, indicative of the group’s cross-border expertise and strength in advising clients with large international portfolios which require advice on large-scale strategic collaboration. Other key contacts include Matthew Warren; Claire Smith, who assists with bespoke supply and distribution agreements; and Ellen Lambrix and Paul Jordan, who are notably skilled in advising on manufacturing agreements and logistics agreements, respectively, for large retailers.
Legal 500 Editorial commentary
- Profile
- Social
Testimonials
Collated independently by Legal 500 research team.
- 'Enthusiastic team who give pragmatic advice.'
- 'I've worked with Adrian Sim for a decade and he's good lawyer to have in your corner. He's energetic and proactive and gives risk-based advice.'
- 'Matthew Warren is extremely thorough and has worked on most of the sophisticated transactions we've done in the last few years. He's a very safe pair of hands.'
- 'They have very significant experience. The people are excellent to work with.'
Key clients
- AstraZeneca
- Kraft Heinz
- LifeArc
- De Beers
- Diageo
- Mondelez
- Oxford Science Enterprises
- Guardian News & Media
- Two Daughters Entertainment
- Syncona
Work highlights
Advised global pharmaceutical company Recordati on its high-value, long-term commercialisation agreement with GSK in relation to its Avodart® and Combodart®/Duodart® urology products.
Advised Kraft Heinz on its landmark talent endorsement and partnership deal with global music superstar Ed Sheeran for the creation of a new range of hot sauces called “Tingly Teds”.
Advised AstraZeneca on a high-profile patent deal with Chinese biotech Usynova to add to AstraZeneca’s oncology pipeline by licensing Usynova’s novel pancreatic cancer therapy in a transaction worth $420m.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Richard Dickinson
Other key lawyers
Ellen Lambrix; Adrian Sim; Claire Smith; Paul Jordan; Matthew Warren